Literature DB >> 27856805

Trends in long-term prognosis after acute coronary syndrome.

Marjo Piironen1,2, Olavi Ukkola1,2, Heikki Huikuri1,2, Aki S Havulinna3, Heli Koukkunen4, Juha Mustonen5, Matti Ketonen5, Seppo Lehto6, Juhani Airaksinen7, Y Antero Kesäniemi1,2, Veikko Salomaa3.   

Abstract

Background Coronary heart disease incidence, mortality and short-term case-fatality have improved substantially during the past decades. Recent changes in the long-term prognosis among survivors of acute coronary syndrome are less well known. Our aim was to investigate the long-term prognosis of acute coronary syndrome. Design An observational myocardial infarction register study. Methods Data was derived from the population based Finnish Myocardial Infarction register. Patients aged 35 or higher, who had their first acute coronary syndrome during 1993-2011 and survived the first 28 days, were included in the analysis ( n = 13,336). Endpoints were fatal and non-fatal cardiovascular disease events and all-cause mortality at one year and three years after the index event. We also compared the prognosis of acute coronary syndrome survivors with the prognosis of an apparently healthy population with the same age, sex and area of residence, derived from the FINRISK study. Results Significant declines over time were observed in the risk of a new cardiovascular disease event. At three year follow-up the age- and study area-adjusted hazard ratio per calendar year was 0.969 (95% confidence interval 0.960-0.977, p = 4.63 × 10-13) among men and 0.969 (95% confidence interval 0.961-0.978, p = 1.01 × 10-11) among women. Despite the improvement in prognosis, the age-standardized three year cardiovascular disease free survival of acute coronary syndrome patients was significantly lower than in the FINRISK control group (for men p = 6.64 × 10-27 and for women p = 2.11 × 10-15). Conclusion The prognosis of acute coronary syndrome survivors has improved during the 18-year period but is still much worse than the prognosis of comparable general population.

Entities:  

Keywords:  Coronary artery disease; acute coronary syndrome; epidemiology; myocardial infarction

Mesh:

Year:  2016        PMID: 27856805     DOI: 10.1177/2047487316679522

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  17 in total

1.  Combined association of triglyceride-glucose index and systolic blood pressure with all-cause and cardiovascular mortality among the general population.

Authors:  Yu Yu; Min Gu; Hao Huang; Sijing Cheng; Yu Deng; Chi Cai; Xuhua Chen; Hongxia Niu; Xiaohui Ning; Wei Hua
Journal:  J Transl Med       Date:  2022-10-20       Impact factor: 8.440

2.  Prognostic value of T-wave morphology parameters in coronary artery disease in current treatment era.

Authors:  Joni M Pirkola; Maija Konttinen; Tuomas V Kenttä; Lauri T A Holmström; M Juhani Junttila; Olavi H Ukkola; Heikki V Huikuri; Juha S Perkiömäki
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-02-27       Impact factor: 1.468

3.  Risk factors for major adverse cardiovascular events after the first acute coronary syndrome.

Authors:  Marjo Okkonen; Aki S Havulinna; Olavi Ukkola; Heikki Huikuri; Arto Pietilä; Heli Koukkunen; Seppo Lehto; Juha Mustonen; Matti Ketonen; Juhani Airaksinen; Y Antero Kesäniemi; Veikko Salomaa
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

4.  Traditional Chinese Medicine ShenZhuGuanXin Granules Mitigate Cardiac Dysfunction and Promote Myocardium Angiogenesis in Myocardial Infarction Rats by Upregulating PECAM-1/CD31 and VEGF Expression.

Authors:  Dan-Ping Xu; De-Zhi Zou; Hui-Liang Qiu; Huan-Lin Wu
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-03       Impact factor: 2.629

5.  Usage of PCI and long-term cardiovascular risk in post-myocardial infarction patients: a nationwide registry cohort study from Finland.

Authors:  Ville Kytö; Tuire Prami; Houssem Khanfir; Pål Hasvold; Eeva Reissell; Juhani Airaksinen
Journal:  BMC Cardiovasc Disord       Date:  2019-05-22       Impact factor: 2.298

6.  The clinical value of the PRECISE-DAPT score in predicting long-term prognosis in patients with acute myocardial infarction.

Authors:  Takuya Ando; Kazuhiko Nakazato; Yusuke Kimishima; Takatoyo Kiko; Takeshi Shimizu; Tomofumi Misaka; Shinya Yamada; Takashi Kaneshiro; Akiomi Yoshihisa; Takayoshi Yamaki; Hiroyuki Kunii; Yasuchika Takeishi
Journal:  Int J Cardiol Heart Vasc       Date:  2020-06-07

7.  Serum albumin level for prediction of all-cause mortality in acute coronary syndrome patients: a meta-analysis.

Authors:  Lingjun Zhu; Miaomiao Chen; Xiaoping Lin
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

8.  Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models.

Authors:  Ralph K Akyea; Jo Leonardi-Bee; Folkert W Asselbergs; Riyaz S Patel; Paul Durrington; Anthony S Wierzbicki; Oluwaseun H Ibiwoye; Joe Kai; Nadeem Qureshi; Stephen F Weng
Journal:  BMJ Open       Date:  2020-07-27       Impact factor: 2.692

9.  [Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak].

Authors:  Jorge Solano-López; José Luis Zamorano; Ana Pardo Sanz; Ignacio Amat-Santos; Fernando Sarnago; Enrique Gutiérrez Ibañes; Juan Sanchis; Juan Ramón Rey Blas; Joan Antoni Gómez-Hospital; Sandra Santos Martínez; Nicolás Manuel Maneiro-Melón; Roberto Mateos Gaitán; Jessika González D'Gregorio; Luisa Salido; José L Mestre; Marcelo Sanmartín; Ángel Sánchez-Recalde
Journal:  Rev Esp Cardiol       Date:  2020-09-17       Impact factor: 4.753

10.  Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis.

Authors:  Wenjun Pan; Haining Lu; Baotao Lian; Pengda Liao; Liheng Guo; Minzhou Zhang
Journal:  Cardiovasc Diabetol       Date:  2019-12-11       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.